BioHarvest Sciences Inc revealed that Steven Lehrer had been appointed to its board of advisors in a bid to leverage the company's biotech technology platform in life science-based businesses.
Lehrer has 40 years of biotech experience and will enhance the board with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D, the company noted.
"Steven's extensive experience in pharmaceutical, biopharmaceutical and biosimilar R&D, regulatory, operations and commercialization will be a great addition to the board of advisors," Ilan Sobel, CEO of BioHarvest, told investors in a statement.
"At this critical phase of the company's growth, Steven's experience and involvement will play an important role in the company's quest to become a biotech leader."
READ: BioHarvest Sciences welcomes David Tsur to its board of directors
Lehrer added: "I strongly believe in the potential of the proprietary BioFarming technology to make a significant impact on multiple verticals of the life science-based businesses. I look forward to working with my fellow advisors as well as with the company's board and management to realize this potential."
Lehrer has built and run businesses in the US, EU, Brazil, India, Japan, and SEA and currently sits on the board of directors of two life science companies, one of which is not for profit.
Previously, he was Head of Biologicals at Cipla Ltd, CEO of Cipla BioTec, President of Glycominds Ltd, EVP of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) and was a division president of Monsanto. He has also worked with McKinsey & Co, and Proctor & Gamble Corporation.
Contact the writer at giles@proactiveinvestors.com